JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan International Research Enhanced Equity ETF
JIRE
|
+$4.16B |
| 2 |
Microsoft
MSFT
|
+$2.29B |
| 3 |
Amazon
AMZN
|
+$2B |
| 4 |
UnitedHealth
UNH
|
+$1.76B |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.42B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$4.61B |
| 2 |
Vanguard Short-Term Bond ETF
BSV
|
+$1.58B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$689M |
| 4 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$659M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.28% |
| 2 | Technology | 15.04% |
| 3 | Healthcare | 12.52% |
| 4 | Financials | 10.55% |
| 5 | Consumer Discretionary | 7.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
TRHC
4501
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
| $385K | ﹤0.01% |
149,741
-85,976
| -36% | -$323K |
2017 Q3
19 quarters
|
|
4502
Schwab US Aggregate Bond ETF
SCHZ
$10.5B
| $383K | ﹤0.01% |
16,004
-638
| -4% | -$15.4K |
2017 Q4
18 quarters
|
|
4503
York Water
YORW
$498M
| $383K | ﹤0.01% |
9,476
-2,251
| -19% | -$91.1K |
2015 Q4
26 quarters
|
|
4504
iShares US Infrastructure ETF
IFRA
$4.03B
| $381K | ﹤0.01% |
+11,188
| New | +$413K |
2022 Q2
0 quarters
|
|
4505
Direxion Daily Small Cap Bear 3x ETF
TZA
$244M
| $380K | ﹤0.01% |
815
-323
| -28% | -$129K |
2020 Q1
9 quarters
|
|
|
OSG
4506
Octave Specialty Group
OSG
$199M
| $379K | ﹤0.01% |
33,444
-350,442
| -91% | -$3.33M |
2013 Q2
36 quarters
|
|
|
AXDX
4507
DELISTED
Accelerate Diagnostics
AXDX
| $377K | ﹤0.01% |
37,934
-3,902
| -9% | -$34.5K |
2017 Q4
18 quarters
|
|
4508
ARK Space & Defense Innovation ETF
ARKX
$772M
| $376K | ﹤0.01% |
27,975
+1,310
| +5% | +$19.8K |
2021 Q2
4 quarters
|
|
|
CTIC
4509
CALL
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $376K | ﹤0.01% |
+63,000
| New | +$323K |
2022 Q2
0 quarters
|
|
4510
908 Devices
MASS
$521M
| $375K | ﹤0.01% |
18,185
+3,573
| +24% | +$60K |
2021 Q1
5 quarters
|
|
4511
Core Laboratories
CLB
$458M
| $374K | ﹤0.01% |
18,856
-49,156
| -72% | -$1.31M |
2013 Q2
36 quarters
|
|
4512
State Street SPDR Portfolio TIPS ETF
SPIP
$1B
| $374K | ﹤0.01% |
13,588
-625,551
| -98% | -$18M |
2021 Q2
4 quarters
|
|
4513
PUT
Beam Therapeutics
BEAM
$2.52B
| $372K | ﹤0.01% |
+9,600
| New | +$382K |
2022 Q2
0 quarters
|
|
4514
Consumer Portfolio Services
CPSS
$200M
| $372K | ﹤0.01% |
36,341
+4,280
| +13% | +$52.2K |
2021 Q1
5 quarters
|
|
|
JMIA
4515
Jumia Technologies
JMIA
$925M
| $371K | ﹤0.01% |
61,352
-8,653
| -12% | -$63.3K |
2020 Q2
8 quarters
|
|
4516
VanEck Video Gaming and eSports ETF
ESPO
$252M
| $370K | ﹤0.01% |
7,767
-5,988
| -44% | -$307K |
2020 Q4
6 quarters
|
|
4517
Pacer WealthShield ETF
PWS
$24.1M
| $370K | ﹤0.01% |
+12,045
| New | +$370K |
2022 Q2
0 quarters
|
|
4518
CALL
State Street Technology Select Sector SPDR ETF
XLK
$130B
| $369K | ﹤0.01% |
5,800
-600,000
| -99% | -$41.8M |
2020 Q1
9 quarters
|
|
4519
ProShares S&P Kensho Cleantech ETF
CTEX
$4.58M
| $367K | ﹤0.01% |
12,701
-7,526
| -37% | -$228K |
2021 Q4
2 quarters
|
|
|
NOVA
4520
CALL
DELISTED
Sunnova Energy
NOVA
| $367K | ﹤0.01% |
+19,900
| New | +$381K |
2022 Q2
0 quarters
|
|
|
CRZN
4521
DELISTED
Corazon Capital V838 Monoceros Corp Class A Ordinary Shares
CRZN
| $367K | ﹤0.01% |
+37,482
| New | +$367K |
2022 Q2
0 quarters
|
|
4522
Amplify Cybersecurity ETF
HACK
$3.35B
| $366K | ﹤0.01% |
+7,987
| New | +$401K |
2022 Q2
0 quarters
|
|
|
AHT
4523
Ashford Hospitality Trust
AHT
$14.6M
| $364K | ﹤0.01% |
6,083
+3,772
| +163% | +$254K |
2020 Q4
6 quarters
|
|
4524
Invesco Global Clean Energy ETF
PBD
$116M
| $364K | ﹤0.01% |
18,568
+3,348
| +22% | +$72.5K |
2020 Q4
6 quarters
|
|
4525
CALL
TripAdvisor
TRIP
$984M
| $363K | ﹤0.01% |
+20,400
| New | +$484K |
2022 Q2
0 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2022 Portfolio in Review
As of Q2 2022, JP Morgan Chase held 7,270 positions worth $718B, down 14% from $830B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q2 2022 filing shows 568 new, 2,561 increased, 2,728 reduced and 609 closed positions. Its largest new stake was JPMorgan International Research Enhanced Equity ETF: 85,906,762 shares worth $4.15B. The largest sale was JPMorgan BetaBuilders Europe ETF, an estimated $4.61B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 27% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q2 2022 buy was JPMorgan International Research Enhanced Equity ETF: 85,906,762 shares worth $4.15B.
- JP Morgan Chase added most to Microsoft in Q2 2022, an estimated $2.29B increase.
- JP Morgan Chase's biggest Q2 2022 reduction was JPMorgan BetaBuilders Europe ETF, cutting an estimated $4.61B.
- JP Morgan Chase fully exited Cerner Corp in Q2 2022, selling an estimated $608M.
- JP Morgan Chase's ten largest holdings make up 18% of its $718B portfolio in Q2 2022.
- JP Morgan Chase opened 568 new positions and closed 609 in Q2 2022.
- JP Morgan Chase's portfolio value fell 14% quarter-over-quarter to $718B.
Based on JP Morgan Chase's 13F filing for Q2 2022, filed 11 Aug 2022.